----item----
version: 1
id: {F5F6E63E-E3C9-4183-8832-8C4238B2AD7D}
database: master
path: /sitecore/content/Pharma/ScripIntelligence/Home/Commercial/Strategy
parent: {D28BD55A-015D-4B51-8CA7-5A60C6B7463E}
name: Strategy
master: {00000000-0000-0000-0000-000000000000}
template: {77604558-3056-497B-93D8-E53BC5619DDB}
templatekey: Topic Page

----version----
language: en
version: 1
revision: 14c0af46-99d3-4168-9577-9248f109cf3c

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 8

Strategy
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 8

Strategy
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 8

Strategy
----field----
field: {04BF00DB-F5FB-41F7-8AB7-22408372A981}
name: __Final Renderings
key: __final renderings
content-length: 1976

<r xmlns:p="p" xmlns:s="s" p:p="1"><d id="{FE5D7FDF-89C0-4D99-9AA3-B5FBD009C9F3}"><r uid="{6AE40D8A-3A76-4223-9F99-7BE6AA4C753C}" p:before="r[@uid='{CAECA8B1-D9CF-4139-973E-2FE2CBD7C79D}']" s:ds="{5687C750-F5BB-49B1-BC6C-D210D858B52A}" s:id="{8C64BF41-EFAF-4867-A5A1-91EEB97F2985}" s:ph="/main-content/right-curated-content_2c501d2b-c082-42c3-8820-223492875345" /><r uid="{CAECA8B1-D9CF-4139-973E-2FE2CBD7C79D}" p:before="r[@uid='{E34AD36E-5A7C-4F67-81D7-F09661B4CF4F}']" s:ds="{9F60EDE4-453A-4CE8-B1AA-C04B8B1002C6}" s:id="{A94F54D2-AD2B-4921-82B3-5093C020674C}" s:par="Show Image=1" s:ph="/main-content/left-curated-content_2c501d2b-c082-42c3-8820-223492875345" /><r uid="{E34AD36E-5A7C-4F67-81D7-F09661B4CF4F}" p:before="r[@uid='{E56088DC-F210-4139-9734-FC80760B7775}']" s:ds="{88B39557-53FF-4FE5-B425-A4EDFAC0E699}" s:id="{A94F54D2-AD2B-4921-82B3-5093C020674C}" s:par="Show Image" s:ph="/main-content/left-curated-content_2c501d2b-c082-42c3-8820-223492875345" /><r uid="{E56088DC-F210-4139-9734-FC80760B7775}" p:before="r[@uid='{2C501D2B-C082-42C3-8820-223492875345}']" s:id="{1AA9B776-B2D0-4B04-B118-CE22D1263656}" s:ph="main-content" /><r uid="{2C501D2B-C082-42C3-8820-223492875345}" p:before="r[@uid='{9ADF04C3-6BAA-4AD6-907A-85A3F016E28F}']" s:id="{3EFF8328-17E2-41E9-BBCB-E4361A60D5C9}" s:ph="main-content" /><r uid="{9ADF04C3-6BAA-4AD6-907A-85A3F016E28F}" p:before="r[@uid='{0F6A6227-C265-4521-8F6D-FA78653AE581}']" s:ds="" s:id="{17FDDCB4-4745-4113-9DF9-D003DD6231E9}" s:par="Display Title=1&amp;Number To Display={9AF30384-21C4-4341-A825-190E44F87A7E}&amp;Subjects={09212D57-26F8-47A3-9592-B0A92A1D55EA}" s:ph="/main-content/two-column-curated_c0a1983c-fb07-4460-84db-90dc9a162294" /><r uid="{0F6A6227-C265-4521-8F6D-FA78653AE581}" p:before="r[@uid='{C0A1983C-FB07-4460-84DB-90DC9A162294}']" /><r uid="{C0A1983C-FB07-4460-84DB-90DC9A162294}" s:ds="{EA6FAC5A-71D6-4BCB-AAF9-210A78A1CF95}" s:id="{FEFB319E-28B6-4BE9-B2F2-655329858135}" s:ph="main-content" /></d></r>
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160424T024203Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 15

sitecore\deweyd
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

14c0af46-99d3-4168-9577-9248f109cf3c
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160513T215631Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 17

sitecore\lafflerm
----field----
field: {001DD393-96C5-490B-924A-B0F25CD9EFD8}
name: __Lock
key: __lock
content-length: 5

<r />
